Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE183403 |
METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity
|
98 |
|
Xiaoyang Dou | Aug 16, 2024 | |||
GSE241222 |
IGF2BP3 promotes mRNA degradation through internal m7G modification
|
52 |
|
Xiaoyang Dou | Jul 13, 2024 | |||
GSE205714 |
RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid differentiation
|
138 |
|
Xiaoyang Dou | Jun 15, 2023 | |||
GSE203581 |
Globally reduced N6-methyladenosine (m6A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration
|
56 |
|
Xiaoyang Dou | Jun 09, 2023 | |||
GSE183401 |
METTL14 is a chromatin regulator independent of RNA N6-methyladenosine (nascent tRNA)
|
|
16 |
|
Xiaoyang Dou | Aug 16, 2024 | ||
GSE203578 |
N6-methyladenosine regulates RNA metabolism and neurodegeneration in C9ORF72-ALS/FTD [seq_polyA_RNA-RIP]
|
10 | Xiaoyang Dou | Jun 09, 2023 | ||||
GSE216958 |
YTHDF2-m6A-NF-kB axis controls anti-tumor immunity through regulating intratumoral Treg survival and function [RIP-seq]
|
|
6 | Xiaoyang Dou | Jun 07, 2023 | |||
GSE216960 |
YTHDF2/m6A/NF-κB axis controls anti-tumor immunity by regulating intratumoral Tregs
|
16 | Xiaoyang Dou | Jun 06, 2023 | ||||
GSE230418 |
YTHDF2-m6A-NF-kB axis controls anti-tumor immunity through regulating intratumoral Treg survival and function
|
|
4 | Xiaoyang Dou | Jun 07, 2023 | |||
GSE269961 |
Chromatin-associated LTR RNA m5C oxidation by TET2 regulates chromatin state and leukemogenesis [seq_RNA-caRNA]
|
|
27 | Xiaoyang Dou | Jul 25, 2024 | |||
GSE269962 |
IGF2BP3 promotes mRNA degradation through internal m7G modification [seq_Ribo]
|
|
12 | Xiaoyang Dou | Jul 15, 2024 | |||
GSE271463 |
Chromatin-associated LTR RNA m5C oxidation by TET2 regulates chromatin state and leukemogenesis [seq_RNA-caRNA-m5C-MeRIP]
|
|
12 | Xiaoyang Dou | Jul 25, 2024 |